D-0584-2026 Class II Ongoing
FDA drug recall D-0584-2026 was initiated by Lannett Company Inc. on May 27, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint. The recall status is ongoing. Affected quantity: 3984 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 10, 2026
- Initiation Date
- May 27, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3984 bottles
Product description
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
Reason for recall
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 25282724A, Exp. Date 2027/01
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0584-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026